Navigation Links
Understand How Sleep Impacts Learning and Memory
Date:11/26/2007

"Your most valuable asset is your consciousness," said Walter. "That is why I wrote this book."

About the Author

Timothy J. Walter, M.D. received his undergraduate degree from Stanford University and his medical degree from The Ohio State University College of Medicine. He went on to do a residency in neurology at Georgetown University Hospital and a fellowship in sleep medicine and neurophysiology at The Cleveland Clinic Foundation. He is board certified in neurology and sleep medicine. He is currently the co-medical director of Capitol Sleep Medicine Sleep Diagnostic Center in Grove City, Ohio.

Contact:

Timothy J. Walter, M.D.

Capitol Sleep Medicine / Lotus Magnus

2441 Old Stringtown Road

Grove City, OH 43123

(614) 317-9990

(614) 317-9905 fax

tjwmd@capitolsleep.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Timothy J. Walter, M.D.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Informational handout key to giving parents a better understanding of CT radiation risks
2. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
3. New understanding of basic units of memory
4. EURYI project to understand how the brain wires during embryogenesis
5. Whole Foods Market(R) Helps Shoppers Understand the Benefits of Natural Cosmetics
6. Optical scientist honored for understanding and improving vision
7. Increased Understanding Called for During November National Alzheimers Disease Awareness Month by Los Angeles Jewish Homes Medical Director
8. Time to Set Kids Back-to-School Sleep Clocks
9. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
10. Sleepless Kids Are Troubled Kids
11. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...2008) Patients with chronic hepatitis C (HCV) inf...according to a study published in Clinical Gastro...f the American Gastroenterological Association (AG...issue scarring. Additionally, patients with modera...
...low for testing of new drugs for vision-robbing di... -- The first animal model of age-related macular ... Clinic researchers. , This mouse model will help ...lindness in the elderly. , The researchers created...
... Members, Appoints New CEO -, BALTIMORE, Jan. 28 ...proving the healthcare of chronically ill seniors,...Patterson, has nominated five,new directors to the..., Patrick Hervy, who will remain on XLHealth,s bo...
...s a high probability that people who are prone to ...hat susceptibility through their genes, University...the Feb. 1 issue of The Journal of Infectious Dise...ility. The researchers further say they pinpointed...
...rant for Suicide Awareness Voices of,Education (SA...ployee with Cargill, earned the company,s Cargill ...rvice for his work as a volunteer with Suicide,Awa...to 100 employees and retirees internationally who ...
...ogical interventions for cancer patients do more t...prove health, new research suggests. , A study of...articipated in a psychological intervention progra... who exercised received a higher dose of their che...
Other Medicine News:Health News:Regular marijuana use increases risk of hepatitis C-related liver damage 2Health News:Regular marijuana use increases risk of hepatitis C-related liver damage 3Health News:Mouse Model of Age-Related Macular Degeneration Developed 2Health News:XLHealth Corporation Announces Executive Changes 2Health News:Study finds genetic link to human herpes susceptibility 2Health News:Study finds genetic link to human herpes susceptibility 3Health News:Volunteer for National Suicide Prevention Agency Earns Cargill Award 2Health News:Intervention program boosts health, reduces symptoms in breast cancer patients 2Health News:Intervention program boosts health, reduces symptoms in breast cancer patients 3
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Watching movies featuring characters who smoke negatively influences Mexican American teens 10968 1Watching movies featuring characters who smoke negatively influences Mexican American teens 10968 2Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 1Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 2Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 3Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 4Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 5Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 6Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 7Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 8Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 9Reportlinker Adds Renal Disease Treatments 3A Products and Therapies 62496 10Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 1Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 2Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 3Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 4Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 5Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 6Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 7Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 8Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies 3A Global Markets 62492 9
...ical Significance, FRAZER, Pa., May 01, 2007 /PR...clinical trial presented today at the 59th Annual,...Boston highlights,data demonstrating that FENTOR...al for the treatment of breakthrough pain in patie... opioids around-the,clock to manage their persis...
...- Genentech, Inc. (NYSE:DNA),and Biogen Idec, Inc.... Phase II clinical study of Rituxan(R) (rituximab)...erosis (RRMS) were,presented today at the American...n. Rituxan is a therapeutic antibody that targets ...There remains a great need for safe and effective ...
Other Medicine Technology:Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 2Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 3Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 4Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 5Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 6Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 7Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: